Ulipristal is a safe and effective option for women with uterine fibroids, according to two new studies published in the New England Journal of Medicine. In both studies, the oral selective progesterone receptor modulator was well-tolerated, rapidly reduced excessive bleeding, and decreased the size... More »
William Parker, MD discusses the use of MRI in diagnosing and managing uterine fibroids. Dr. Parker's upcoming Clinical Opinion article, “The utility of MRI for the surgical treatment of women with uterine fibroid tumors”, will be published in the American Journal of Obstetrics and Gynecology in... More »
The VizAblate System is a device that is inserted through the cervix into the endometrial cavity, and uses radiofrequency energy to ablate individual fibroids while seeing what he or she is doing with intrauterine sonography. More »
A 35-year-old nulliparous woman with a giant uterine myoma is described. During the past three years she had developed a intramural myoma and a subserous myoma. Although the lesions were excised, both reappeared and were treated with GnRH analogues for 6 months. More »
Feasibility of laparoscopic myomectomy is now accepted even if the attention is still stressed on technical difficulties due to myoma location and size and difficulty in reapproximating the incision by laparoscopic suturing that requires perfect mastery of endoscopic suturing. More »
The objective of this manuscript is to study the pregnancy rate and the prognostic factors for conception after myomectomy carried out in cases of infertility. More »
If you need treatment for fibroids, there are a number of options available to you. Your choices should be guided by the medical problems the fibroids are causing, your desire to have children, and your feelings and thoughts about surgery or other options. I think it is important for you to know all... More »
Like many of my patients, my life revolves around information. Personally, I use the same technology as most of you to keep track of obligations and loved ones. Professionally, the Houston Fertility Center team uses technology and constant communication to manage our patients' treatment plans.
Here's a situation that illustrates how fantastic medical advances don't always translate to patients benefiting in the clinic. For that to happen, the science needs to be carried along a pipeline of practitioner communication, all the way to the patient.
I know what you're thinking: How can an issue like infertility teach us about customizing healthcare? And how can the assisted reproduction field help raise standards in women's healthcare? But it can, and it does… or it should.
Dural venous sinus thrombosis (VST) is a rare stroke subtype with a spectrum of clinical presentations and causes that occurs in all age groups, but primarily affects middle-aged women. Causes range from precipitating head injury to hypercoagulability from oral contraceptives, pregnancy, and puerperium (). Cases refractory to systemic anticoagulation may benefit from endovascular thrombolysis and/or thrombectomy (). When administering thrombolytic therapy, it is imperative to be aware of specific bleeding
Uterine leiomyomas, or fibroids, are benign, hormone-sensitive, smooth-muscle tumors that occur in 20 to 40% of women of reproductive age. The most common symptoms are menorrhagia and iron-deficiency anemia, which may lead to chronic fatigue that may not be adequately controlled with iron…
Uterine leiomyomas (fibroids) are the most common tumors in women of reproductive age and a cause of significant morbidity in this patient population. Depending on the fibroid location, they can be the cause of a variety of symptoms, such as abnormal uterine bleeding, constipation, urinary frequency, and pain. Historically, hysterectomy has been the primary treatment option, and uterine fibroids remain the leading cause for hysterectomy in the United States. However, women who do not wish to undergo hysterectomy now have a variety of less invasive options available, including uterine artery embolization. This article discusses uterine artery embolization as well as some of the other treatment strategies for symptomatic uterine fibroids. In many situations, there may be no single best treatment option but several viable alternatives. Each option is discussed with consideration of outcomes, complications, and, when possible, cost-effectiveness. The recommendations in this article are
To investigate how uterine artery embolization (UAE) might alter the risk profile for pregnancies complicated by fibroids.|Systematic literature review and meta-analysis of existing studies.|Academic reproductive medicine unit.|Women with fibroids.|A systematic literature review, raw data extraction, and data analysis.|Rates of miscarriage, preterm delivery, malpresentation, intrauterine growth restriction (IUGR), cesarean delivery, and postpartum hemorrhage (PPH).|Two hundred twenty-seven completed pregnancies after UAE were identified. Miscarriage rates were higher in UAE pregnancies (35.2%) compared with fibroid-containing pregnancies matched for age and fibroid location (16.5%) (odds ratio [OR] 2.8; 95% confidence interval [CI] 2.0-3.8). The UAE pregnancies were more likely to be delivered by cesarean section (66% vs. 48.5%; OR 2.1; 95% CI 1.4-2.9) and to experience PPH (13.9% vs. 2.5%; OR 6.4; 95% CI 3.5-11.7). Rates of preterm delivery (14% vs. 16%; OR 0.9; 95% CI 0.5-1.5), IUGR
Uterine leiomyomas (fibroids), the most common benign tumor in women of childbearing age, can cause symptoms including dysmenorrhea, menorrhagia, urinary symptoms, pain and infertility. Hysterectomy is a common approach to treating uterine fibroids, and less invasive surgical approaches such as myomectomy and uterine artery embolization also have been shown to alleviate symptoms. Magnetic resonance-guided focused ultrasound surgery (MRgFUS) is the only totally non-invasive surgical approved method for treating uterine fibroids. In clinical trials, MRgFUS resulted in significant relief of uterine fibroid symptoms. The safe and effective use of MRgFUS is affected by fibroid type and location, position relative to adjacent anatomical structures and the presence of co-existent pelvic disease. Additionally, successful outcomes with MRgFUS have been correlated with the volume of fibroids ablated during the procedure. Thus, selection of patients in whom sufficient fibroid volumes can be
The parent study documents fibroid number, size, and location with a 7 week ultrasound examination. ... With the additional postpartum ultrasound proposed here, data on fibroid number, size, and location through pregnancy and postpartum uterine
A similar compound, mifepristone ( Registered Trademark), reduced fibroid size when given for twelve weeks. ... This study will compare fibroid size, hormone levels and symptoms before and during daily administration of CDB-2914 ( 10 or 25 mg) or placebo
of in vitrofertilization ( IVF), to provide guidelines on the number of embryos to transfer in IVF-embryo transfer ( ET) in order to optimize healthy live births and minimize multiple pregnancies. ... Search terms included embryo transfer ( ET),
other disorders - associated with the PDGFRA gene. PDGFRA gene mutations that lead to a constitutively active PDGFRA protein are also associated with inflammatory fibroid polyps, which are small, noncancerous ( benign) tumors
A weekly compilation of articles appearing in recently released journals and newsletters, including articles funded by AHRQ or authored by AHRQ researchers, mentioning or discussing AHRQ staff, activities, and publications/products, or other research using AHRQ data or products.
Hysterectomy Resource Center Hysteroscopy Training In Vitro Fertilization (IVF) ... Hysterectomy Training Hysteroscopy In Vitro Fertilization (IVF) Laparoscopy Nursing ...
Hysterectomy Resource Center Hysteroscopy Training In Vitro Fertilization (IVF) ... Hysterectomy Training Hysteroscopy In Vitro Fertilization (IVF) Laparoscopy Nursing ...
Hysterectomy Resource Center Hysteroscopy Training In Vitro Fertilization (IVF) ...OB-GYN-LMessages by date Messages sorted by: ... 19:37 -0700 Montgomery Lynn MD IVF training ...
Hysterectomy Resource Center Hysteroscopy Training In Vitro Fertilization (IVF) ... Hysterectomy Training Hysteroscopy In Vitro Fertilization (IVF) Laparoscopy Nursing ...
Hysterectomy Resource Center Hysteroscopy Training In Vitro Fertilization (IVF) ... Hysterectomy Training Hysteroscopy In Vitro Fertilization (IVF) Laparoscopy Nursing ...
Physician Performance Goals Are Great, But Balance Is More Realistic Jennifer Frank, MD, May 15, 2012 Performance measurements for physicians are well-intentioned and get me to rethink how I practice. But in the end I won't make the goals, so I'll have to go with balance over perfection.
Designing the Perfect Business Card for Your Medical Practice C. Noel Henley, MD, May 11, 2012 Does your business card say anything substantive about the valuable work you do in your practice? Here’s how to re-design your next business card for maximum impact and engagement.
Registered Nurses an Ideal Fit for Primary Care Practices Audrey "Christie" McLaughlin, RN, May 10, 2012 Here are four good reasons to hire a registered nurse for your primary care practice …maybe even instead of a medical assistant.
The Five Biggest Medical Practice Marketing Mistakes James Doulgeris, May 10, 2012 There are best practices to marketing your practice, but often, success is more about knowing what not to do. Here are the five most common pitfalls …and how to avoid them.
Can You Practice Medicine and Manage Your Practice? Rosemarie Nelson, May 9, 2012 Whether you practice alone, or in a group, if you're trying to see patients in this pay-for-volume environment and also run the business of your practice, you may be missing out on important opportunities.
